RAXORULIMOGENE BELZOVACIREPVEC EXPRESSED IGGL-T2A-.ALPHA.CTLA4-IGGH

UNII:	Z7K8WVV2H3
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	RAXORULIMOGENE BELZOVACIREPVEC EXPRESSED IGGL-T2A-.ALPHA.CTLA4-IGGH
GSRS Full Record:	Z7K8WVV2H3 i

Raxorulimogene belzovacirepvec expressed IgGL–T2A-αCTLA4-IgGH
Raxorulimogene belzovacirepvec expressed anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) immunoglobulin G1 γ1-chain fused via a synthetic T2A peptide with human immunoglobulin kappa chain (anti-CTL4 antibody) with the Igκ signal sequence for the heavy chain and an anti-CD79B light chain signal for the light chain

Inxight Drugs
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RAXORULIMOGENE BELZOVACIREPVEC EXPRESSED IGGL-T2A-.ALPHA.CTLA4-IGGH

Synonyms and Mappings

Resources